Bo Hu
Beijing Key Laboratory Of Intelligent Clinical Data And AI Model Driven Innovative Drug Development, Beijing Key Laboratory Of Drug Innovation For Neuro Oncology
Beijing, 100069, China
Beijing, 100069, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
AI-guided design of self-assembled flavonoid-cisplatin nanoparticles enhances triple-negative breast cancer therapy via three cell-death pathways.
Journal: Nanoscale
Published: June 17, 2026
An evaluation of dual-layer detector spectral CT for the estimation of MRI proton density fat fraction of the liver.
Journal: Quantitative imaging in medicine and surgery
Published: December 02, 2025
A three-material model for dual-layer detector spectral computed tomography measurements of marrow adipose tissue and bone mineral density.
Journal: JBMR plus
Published: January 23, 2025
A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer.
Journal: Journal of medicinal chemistry
Published: May 10, 2024
pH-Responsive, Self-Assembled Ruthenium Nanodrug: Dual Impact on Lysosomes and DNA for Synergistic Chemotherapy and Immunogenic Cell Death.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: November 26, 2023
The ruthenium complex assists in nuclear targeting and selective killing of tumor cells.
Journal: Nanoscale
Published: June 26, 2023
Substantial Progress Yet Significant Opportunity for Improvement in Stroke Care in China.
Journal: Stroke
Published: May 26, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026